Additionally, in vivo validation in PKP2+/− rats corroborated these findings: KA (20 mg/kg/day, i.g.)can improve the wide QRS waveform and alleviate arrhythmia (Supplementary Figure S3). The gene discussed is PKP2; the disease is Arrhythmia.